- Home
- /
- Treatment
- /
- Page 89
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
1-Cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea | Acute myeloid leukemia | Astex Therapeutics Ltd;436 Cambridge Science Park, CB4 0QA; | November 12, 2009 | |
Amifampridine phosphate | Lambert-Eaton Myasthenic Syndrome | Catalyst Pharmaceuticals, Inc.;355 Alhambra Circle, Suite 1250;Coral Gables, Florida, 33134 | November 12, 2009 | |
3,4-Diaminopyridine phosphate | Lambert-Eaton Myasthenic Syndrome | Catalyst Pharmaceutical Partners, Inc.;355 Alhambra Circle, Suite 1500;Coral Gables, FL, 33134 | November 12, 2009 | |
Hypothiocyanite and lactoferrin | Cystic fibrosis | Alaxia Biotechnologies Sante;3-11 Rue de la Perlerie, F- 69120 Vaulx-en-velin; | November 5, 2009 | |
Cyclic pyranopterin monophosphate (cPMP) | Molybdenum cofactor deficiency type A (MoCD) | Alexion Pharmaceuticals, Inc.;100 College Street;New Haven, Connecticut, 06510 | November 5, 2009 | |
Exon 44 specific phosphorothioate oligonucleotide | Duchenne muscular dystrophy | BioMarin Pharmaceutical, Inc.;105 Digital Drive;Novato, California, 94949 | November 5, 2009 | |
Varbulin | Glioblastoma | Myrexis, Inc.;305 Chipeta Way;Salt Lake City, Utah, 84108 | November 5, 2009 | |
Salmeterol xinafoate/fluticasone propionate | Symptomatic exophthalmos associated with thyroid related eye disease | Lithera, Inc.;9191 Towne Center Drive;San Diego, California, 92122 | October 29, 2009 | |
Diannexin | Prevention of ischemia-reperfusion injury in solid organ transplants | Astellas Pharma Global Development, Inc.;Three Parkway North;Deerfield, Illinois, 60015 | October 28, 2009 | |
Dasiprotimut-T | Follicular lymphoma | Biovest International, Inc.;324 S. Hyde Park Avenue;Tampa, Florida, 33606 | October 28, 2009 | |
Caprine hyperimmune serum against HIV lysate | Amyotrophic lateral sclerosis | Daval International Limited;50 Lady Somerset Road; | October 28, 2009 | |
S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinly-GNNDESNISFKEK | Pancreatic Cancer | MBiotec GmBH;Hohenweg 13, D-82229 Seefeld; | October 20, 2009 | |
Bevacizumab | Melanoma stages IIb through IV as part of a combination chemotherapy regimen | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | October 13, 2009 | |
4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione | Progressive supranuclear palsy | NOSCIRA, S.A.;Avda. de la Industria, 52;Madrid | October 13, 2009 | |
Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1 | Glioblastoma | Apogenix GmbH;Im Meuenheimer Feld 584; | October 13, 2009 | |
(S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate | Carcinoid syndrome | Ipsen Pharma | October 8, 2009 | |
Paclitaxel protein-bound particles for injection suspension | Metastatic Melanoma | Celgene Corporation;400 Connell Drive, Suite 7000;Berkeley Heights, New Jersey, 07922 | October 1, 2009 | |
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser | Prevention of delayed graft function following renal transplant | Araim Pharmaceuticals, Inc.;712 Kitchawan Road;Ossining, New York, 10562 | September 18, 2009 | |
R-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1 H -1,4-benzodiazepine -3-yl]-3-(3-methylaminophenyl)urea | Gastric carcinoids | Trio Medicines Ltd.;Pavillion View, Brighton BN1 1EY; | September 10, 2009 | |
Nucleic acid aptamer binding to tumor cell nucleolin | Acute myeloid leukemia | Antisoma, Inc.;300 Technology Square;Cambridge, Massachusetts, 02139 | September 10, 2009 | |
Cethromycin | Prophylactic treatment of tularemia due to Francisella tularensis | Advanced Life Sciences, Inc.;1440 Davey Road;Woodridge, Illinois, 60517 | September 9, 2009 | |
Cethromycin | Prophylactic treatment of plague due to Yersinia pestis | Advanced Life Sciences, Inc.;1440 Davey Road;Woodridge, Illinois, 60517 | September 9, 2009 | |
Belinostat | T-cell lymphoma | Spectrum Pharmaceuticals, Inc.;157 Technology Drive;Irvine, California, 92618 | September 3, 2009 | |
4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]-amino]-3-fluorophenoxyl]-N-methyl-2-pyridinecarboxamide, p-toluenesulfonate salt | Chronic myeloid leukemia | Deciphera Pharmaceuticals, LLC;643 Massachusetts, Suite 200;Lawrence, Kansas, 66044 | September 3, 2009 | |
Rigosertib | Myelodysplastic syndromes | Onconova Therapeutics, Inc.;375 Pheasant Run;Newtown, Pennsylvania, 18940 | September 3, 2009 |